PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsdwarfism
MeSH D004392 - dwarfism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004700:Endocrine system diseases
0 Companies
0 Drugs
Success rate
D001848:Developmental bone diseases
0 Companies
0 Drugs
Success rate
D030342:Inborn genetic diseases
$
Success rate
D004392: 
Dwarfism
$
Success rate
D003409:Congenital hypothyroidism
0 Companies
0 Drugs
Success rate
D004393:Pituitary dwarfism
$
Success rate
D046150:Laron syndrome
$
Success rate
D000130:Achondroplasia
$
Success rate
D003057:Cockayne syndrome
0 Companies
0 Drugs
Success rate
D050336:Mulibrey nanism
0 Companies
0 Drugs
Success rate
D056846:Weill-marchesani syndrome
0 Companies
0 Drugs
Success rate
D056730:Silver-russell syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
SandozSomatropin Omnitrope  2006-04-12   
Eli LillySomatropin Humatrope  1986-10-16   
Pharmacia & UpjohnSomatropin Genotropin  1995-08-24   
GenentechSomatropin Nutropin  1993-11-17   
Novo NordiskSomatropin Norditropin  2000-06-20   
Ferring PharmaceuticalsSomatropin Zomacton  1995-05-25   
IpsenSomatropin NutropinAq  2001-02-15   
EMD SeronoSomatropin Saizen  1996-10-08   
Somatropin Serostim  1996-08-23   
BioPartnersSomatropin Somatropin Biopartners  2013-08-05   
Somatropin Valtropin  2006-04-24   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
50%
1/2
Phase 3
100%
3/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Eli Lilly
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use